Clinically, we found that TAZ and NANOG formed nuclear puncta in ALDH1+ tumor cells in both pre-treatment and post-treatment samples from the chemoresistant breast cancer patients rather than chemosensitive ones (Fig. 5i and Supplementary Fig. 4k). Here, ALDH1A1 is linked to breast carcinoma.